New insights into the metabolic and molecular basis for diabetic neuropathy

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cellular and Molecular Life Sciences (CMLS)

• Publication date

  2003-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00018-003-3084-xPMID 14625688PMCID PMC11138496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.

  2009cited by this paper
• New aspects on biological activity of C-peptide in IDDM patients.

  2009cited by this paper
• Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy.

  2003cited by this paper
• Proinsulin C‐Peptide Replacement in Type 1 Diabetic BB/Wor‐rats Prevents Deficits in Nerve Fiber Regeneration

  2003cited by this paper
• Preventing Superoxide Formation in Epineurial Arterioles of the Sciatic Nerve from Diabetic Rats Restores Endothelium-dependent Vasodilation

  2003cited by this paper
• C‐peptide enhances insulin‐mediated cell growth and protection against high glucose–induced apoptosis in SH‐SY5Y cells

  2003cited by this paper
• Insulin Deficiency Rather than Hyperglycemia Accounts for Impaired Neurotrophic Responses and Nerve Fiber Regeneration in Type 1 Diabetic Neuropathy

  2003cited by this paper
• Insulin‐like growth factor‐1 protects peroxynitrite‐induced cell death by preventing cytochrome c‐induced caspase‐3 activation

  2002cited by this paper
• The role of sodium channels in cell adhesion.

  2002cited by this paper
• GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/Wor rats.

  2002cited by this paper
• Impaired glucose tolerance and insulinopenia in the GK‐rat causes peripheral neuropathy

  2002cited by this paper
• Tumor Necrosis Factor Induces Apoptosis in Hepatoma Cells by Increasing Ca2+ Release from the Endoplasmic Reticulum and Suppressing Bcl-2 Expression*

  2002cited by this paper
• Altered Tubulin and Neurofilament Expression and Impaired Axonal Growth in Diabetic Nerve Regeneration

  2002cited by this paper
• Early Gene Responses of Trophic Factors in Nerve Regeneration Differ in Experimental Type 1 and Type 2 Diabetic Polyneuropathies

  2002cited by this paper
• Hippocampal neuronal apoptosis in type 1 diabetes.

  2002cited by this paper
• Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives

  2002cited by this paper
• Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF‐obese diabetic rats

  2002cited by this paper
• Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord

  2002cited by this paper
• Neurofilaments in diabetic neuropathy.

  2002cited by this paper
• Impaired intellectual development in children with Type I diabetes: association with HbA1 c, age at diagnosis and sex

  2002cited by this paper
• C-Peptide Prevents Hippocampal Apoptosis in Type 1 Diabetes

  2002cited by this paper
• Effects of protein kinase Cβ inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism

  2002cited by this paper
• Tumor necrosis factor induces apoptosis in hepatoma cells by increasing Ca(2+) release from the endoplasmic reticulum and suppressing Bcl-2 expression.

  2002cited by this paper
• How does glucose generate oxidative stress in peripheral nerve?

  2002cited by this paper
• Oxidative Stress and Programmed Cell Death in Diabetic Neuropathy

  2002cited by this paper
• Implications of altered apoptosis in diabetes mellitus and autoimmune disease

  2001cited by this paper
• Pathophysiology of oxidative stress in diabetes mellitus.

  2001cited by this paper
• Molecular basis for the insulinomimetic effects of C-peptide

  2001cited by this paper
• C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat

  2001cited by this paper
• Altered Immediate Early Gene Expression in Injured Diabetic Nerve: Implications in Regeneration

  2001cited by this paper
• Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy.

  2001cited by this paper
• Myelin Proteolipid Protein : Evidence for the Nonenzymatic Glycosylation of Extracytoplasmic Domains in Normal and Diabetic Animals

  2001cited by this paper
• C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts.

  2001cited by this paper
• Sodium channel beta subunits mediate homophilic cell adhesion and recruit ankyrin to points of cell-cell contact.

  2000cited by this paper
• Role of C-peptide in human physiology.

  2000cited by this paper
• Insulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms

  2000cited by this paper
• Sodium Channel β Subunits Mediate Homophilic Cell Adhesion and Recruit Ankyrin to Points of Cell-Cell Contact*

  2000cited by this paper
• Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction.

  2000cited by this paper
• Beneficial effects of C‐peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus

  2000cited by this paper
• Neuronal Apoptosis After CNS Injury: The Roles of Glutamate and Calcium

  2000cited by this paper
• A sodium channel signaling complex: modulation by associated receptor protein tyrosine phosphatase β

  2000cited by this paper
• Diabetic neuropathy – a continuing enigma

  2000cited by this paper
• Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders.

  2000cited by this paper
• A comparison of diabetic polyneuropathy in Type II diabetic BBZDR/Wor rats and in Type I diabetic BB/Wor rats

  2000cited by this paper
• Insulin-like Growth Factor-1-mediated Neuroprotection against Oxidative Stress Is Associated with Activation of Nuclear Factor κB*

  1999cited by this paper
• Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels.

  1999cited by this paper
• Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort.

  1999cited by this paper
• Only limited effects of aminoguanidine treatment on peripheral nerve function, (Na+,K+)-ATPase activity and thrombomodulin expression in streptozotocin-induced diabetic rats

  1999cited by this paper
• Diabetic neuropathy--the utility of nerve biopsy.

  1999cited by this paper
• Experimental diabetic neuropathy: an update

  1999cited by this paper
• Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB.

  1999cited by this paper
• C-peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin.

  1999cited by this paper
• Brain Insulin Receptors and Spatial Memory

  1999cited by this paper
• Implication of Poly(ADP‐Ribose) Polymerase (PARP) in Neurodegeneration and Brain Energy Metabolism: Decreases in Mouse Brain NAD+ and ATP Caused by MPTP Are Prevented by the PARP Inhibitor Benzamide

  1999cited by this paper
• Protein kinase C effects on nerve function, perfusion, Na+,K+-ATPase activity and glutathione content in diabetic rats

  1999cited by this paper
• Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy.

  1999cited by this paper
• The changing landscape of ischaemic brain injury mechanisms

  1999cited by this paper
• Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.

  1999cited by this paper
• Tumor Necrosis Factor Induces Bcl-2 and Bcl-x Expression through NFκB Activation in Primary Hippocampal Neurons*

  1999cited by this paper
• Differential accumulation of advanced glycation end products in the course of diabetic retinopathy

  1999cited by this paper
• The p53 pathway and apoptosis

  1999cited by this paper
• Specific binding of proinsulin C-peptide to human cell membranes.

  1999cited by this paper
• Neurotrophic factors in the therapy of diabetic neuropathy.

  1999cited by this paper
• Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

  1999cited by this paper
• Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose.

  1999cited by this paper
• Localization of survival motor neuron protein in human apoptotic-like and regenerating muscle fibers, and neuromuscular junctions.

  1999cited by this paper
• NMDA receptor-mediated K+ efflux and neuronal apoptosis.

  1999cited by this paper
• Diabetic neuropathy--the utility of nerve biopsy.

  1999cited by this paper
• Growth Factors and Taurine Protect against Excitotoxicity by Stabilizing Calcium Homeostasis and Energy Metabolism

  1999cited by this paper
• The mitochondrial permeability transition pore and its role in cell death.

  1999cited by this paper
• Neurons undergo apoptosis in animal and cell culture models of diabetes.

  1999cited by this paper
• Apoptosis driven by IP3‐linked mitochondrial calcium signals

  1999cited by this paper
• Aldose reductase inhibitors: therapeutic implications for diabetic complications.

  1999cited by this paper
• A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.

  1999cited by this paper
• Mitochondrial Release of Caspase-2 and -9 during the Apoptotic Process

  1999cited by this paper
• Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis.

  1998cited by this paper
• Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′ end of the aldose reductase gene

  1998cited by this paper
• Inhibitors of the activity of poly (ADP‐ribose) synthetase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts

  1998cited by this paper
• Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis

  1998cited by this paper
• Target tissue production and axonal transport of neurotrophin-3 are reduced in streptozotocin-diabetic rats

  1998cited by this paper
• Mitochondrial control of apoptosis: the role of cytochrome c.

  1998cited by this paper
• The role of calcium in apoptosis.

  1998cited by this paper
• Progression rates of diabetic neuropathy in placebo patients in an 18-month clinical trial. Ponalrestat Study Group.

  1998cited by this paper
• Renal catabolism of advanced glycation end products: the fate of pentosidine.

  1998cited by this paper
• Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress

  1998cited by this paper
• Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment.

  1998cited by this paper
• Tracking Insulin to the Mind

  1998cited by this paper
• Caspases: enemies within.

  1998cited by this paper
• Mitochondria and apoptosis.

  1998cited by this paper
• Bidirectional Regulation of p38 Kinase and c-Jun N-terminal Protein Kinase by Insulin-like Growth Factor-I*

  1998cited by this paper
• Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

  1998cited by this paper
• Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease

  1998cited by this paper
• Serum from patients with type 2 diabetes with neuropathy induces complement-independent, calcium-dependent apoptosis in cultured neuronal cells.

  1998cited by this paper
• Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal.

  1998cited by this paper
• Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.

  1998cited by this paper
• Antiapoptotic signaling by the insulin receptor in Chinese hamster ovary cells.

  1998cited by this paper
• Molecular basis of insulin action.

  1998cited by this paper
• Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses.

  1998cited by this paper
• The Bcl-2 protein family: arbiters of cell survival.

  1998cited by this paper
• Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy.

  1997cited by this paper

• Cilostazol Ameliorates Motor Dysfunction and Schwann Cell Impairment in Streptozotocin-Induced Diabetic Rats

  2024cites this paper
• RGS10 mitigates high glucose-induced microglial inflammation via the reactive oxidative stress pathway and enhances synuclein clearance in microglia

  2024cites this paper
• Axonal transport deficits in the pathogenesis of diabetic peripheral neuropathy

  2023cites this paper
• Ameliorative Effects of Isoeugenol and Eugenol against Impaired Nerve Function and Inflammatory and Oxidative Mediators in Diabetic Neuropathic Rats

  2023cites this paper
• Molecular mechanisms of skin wound healing in non-diabetic and diabetic mice in excision and pressure experimental wounds

  2022cites this paper
• Temporal trend of small nerve fibre degeneration in people with and without type 2 diabetes mellitus

  2021cites this paper
• Assessment of the Effect of C-Peptide Level on Na-K ATPase Activity In Individuals with Type II Diabetic Peripheral Neuropathy

  2021cites this paper
• Impact of the metabolic syndrome on peripheral nerve structure and function in type 2 diabetes

  2021cites this paper
• NGF and Endogenous Regeneration: From Embryology Toward Therapies.

  2021cites this paper
• Non-glucose risk factors in the pathogenesis of diabetic peripheral neuropathy

  2020cites this paper
• Effects of Topical Application of CHF6467, a Mutated Form of Human Nerve Growth Factor, on Skin Wound Healing in Diabetic Mice

  2020cites this paper
• Early Phase of Type 1 Diabetes Decreases the Responsiveness of C-Fiber Nociceptors in the Temporomandibular Joint of Rats.

  2019cites this paper
• Dimethyloxalylglycine (DMOG) and the Caspase Inhibitor "Ac-LETD-CHO" Protect Neuronal ND7/23 Cells of Gluocotoxicity.

  2019cites this paper
• Clinical and Pharmacological basis for the Use of Telmisartan in Patients with Diabetic Neuropathy

  2018cites this paper
• Peripheral Nerve Regeneration after Injury, Repair and Reconstruction in Experimental Diabetes

  2018cites this paper
• ACE factor deficiency theory & its application in diabetes mellitus type II

  2018cites this paper
• Correlation between markers of peripheral nerve function and structure in type 1 diabetes

  2018cites this paper
• Association of down-regulation of calcitonin gene-related peptide and substance P with increase of myocardial vulnerability in diabetic neuropathic rats.

  2017cites this paper
• The Quest for more Research on Painful Diabetic Neuropathy.

  2017cites this paper
• Investigation of the Risk Factors of Diabetic Neuropathy in terms of Pain, Sleep and Quality of Life

  2017cites this paper
• Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy

  2017cites this paper
• Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis.

  2017cites this paper
• Phytochemicals, management of diabetic peripheral neuropathy, experimental evidences

  2017cites this paper
• EXPRESSION OF THE NERVE GROWTH FACTOR DURING EMBRYONIC GROWTH PERIOD OF JAPANESE QUAIL (COTURNIX COTURNIX JAPONICA)

  2016cites this paper
• Glycolytic metabolite methylglyoxal inhibits cold and menthol activation of the transient receptor potential melastatin type 8 channel

  2016cites this paper
• Memorial Neuropathology Review Course Diseases of the Peripheral Nervous System

  2016cites this paper
• Effect of Chinese herbal compound Naofucong (脑复聪) on the inflammatory process induced by high glucose in BV-2 cells

  2016cites this paper
• Study of Complication Profile in Type 2 Diabetes Mellitus Patients at First Visit to Tertiary Care Clinic in Central Indian Context.

  2016cites this paper
• In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes.

  2016cites this paper
• Expression of Activating Transcription Factor 3 ( ATF 3 ) and caspase 3 in Schwann cells and axonal outgrowth after sciatic nerve repair in diabetic BB rats

  2016cites this paper
• Neuroprotective effects of folic acid on experimental diabetic peripheral neuropathy

  2016cites this paper
• Wherefore Art Thou, O Treatment for Diabetic Neuropathy?

  2016cites this paper
• Pain modulation from the brain during diabetic neuropathy: Uncovering the role of the rostroventromedial medulla.

  2016cites this paper
• Nociceptive Alteration by High Sucrose Diet in Hypoestrogenic Wistar Rats

  2016cites this paper
• Polyneuropathy in POEMS syndrome: Alterations in nerve function and morphology.

  2015cites this paper
• Burning through the pain: treatments for diabetic neuropathy

  2015cites this paper
• Oxidative, Metabolic, and Apoptotic Responses of Schwann Cells to High Glucose Levels

  2015cites this paper
• Enhanced GABA action on the substantia gelatinosa neurons of the medullary dorsal horn in the offspring of streptozotocin-injected mice.

  2015cites this paper
• O EFEITO DO USO DE ANTIOXIDANTES NA PREVENÇÃO E TRATAMENTO DA NEUROPATIA DIABÉTICA NO SISTEMA NERVOSO ENTÉRICO

  2015cites this paper
• Identification of Nerve Growth Factor (NGF) Receptor Modulators for Nerve Regeneration

  2015cites this paper
• Положительное влияние ацетил-L-карнитина на болевой синдром, регенерацию нервов и вибрационное чувство у пациентов с хронической диабетической нейропатией. Анализ результатов двух рандомизированных плацебоконтролируемых исследований

  2015cites this paper
• Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.

  2015cites this paper
• Effect of Nobiletin on Diabetic Neuropathy in Experimental Rats

  2015cites this paper
• Age-related obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans

  2015cites this paper
• Regulatory effect of electroacupuncture on ceramide galactosyltransferase expression in sciatic nerve of experimental diabetic rats

  2014cites this paper
• Towards A Possible Therapy for Diabetes Complications

  2014cites this paper
• REMEDIAL EFFECTS OF VITAMIN E AND L-ARGININE ON PERIPHERAL NEUROPATHY IN STREPTOZOTOCIN-INDUCED DIABETIC RATS

  2014cites this paper
• Increased peripherin in sympathetic axons innervating plantar metatarsal arteries in STZ-induced type I diabetic rats

  2014cites this paper
• Mechanisms of diabetic neuropathy: axon dysfunction.

  2014influential citation
• Gender differences in nerve regeneration after sciatic nerve injury and repair in healthy and in type 2 diabetic Goto-Kakizaki rats

  2014cites this paper
• A new paradigm to understand and treat diabetic neuropathy.

  2014cites this paper
• Mesenchymal Stem Cell Therapy in Type 1 Diabetes Mellitus and Its Main Complications: From Experimental Findings to Clinical Practice

  2014cites this paper
• Protective Effects of Vitamin E Against Motor Nerve Conduction Deficit in Diabetic Rats

  2013cites this paper
• Novel pathogenic pathways in diabetic neuropathy.

  2013cites this paper
• Increased Nerve Growth Factor Signaling in Sensory Neurons of Early Diabetic Rats Is Corrected by Electroacupuncture

  2013influential citation
• Protective effect of Jiaweibugan decoction against diabetic peripheral neuropathy

  2013cites this paper
• Peripheral nerve function : metabolic features, clinical assessment, and heat shock protein 27

  2013cites this paper
• Age-dependent slowing of enteric axonal transport in insulin-resistant mice.

  2013cites this paper
• Effects of C-Peptide and / or Insulin Administration on Motor Nerve Conduction Velocity in Diabetic Rats

  2013cites this paper
• Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db−/db− mouse, a type 2 diabetes model

  2012cites this paper
• Expression of activating transcription factor 3 (ATF 3) and caspase 3 in Schwann cells and axonal outgrowth after sciatic nerve repair in diabetic BB rats.

  2012cites this paper
• APOE gene polymorphisms and diabetic peripheral neuropathy

  2012cites this paper
• The role of glutamate in diabetic and in chemotherapy induced peripheral neuropathies and its regulation by glutamate carboxypeptidase II.

  2012cites this paper
• Hydroxytyrosol attenuates peripheral neuropathy in streptozotocin-induced diabetes in rats.

  2012cites this paper
• Protective effect of ferulic acid and resveratrol against alloxan-induced diabetes in mice.

  2012cites this paper
• Nerve growth factor: from the early discoveries to the potential clinical use

  2012cites this paper
• Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves.

  2012cites this paper
• evelopmental regulation of insulin receptor gene in sciatic nerves and role f insulin on glycoprotein P 0 in the Schwann cells

  2012cites this paper
• Protective effect of gliclazide on diabetic peripheral neuropathy through Drp-1 mediated-oxidative stress and apoptosis.

  2012cites this paper
• LEAF EXTRACT TREATMENT ON DIABETIC NEUROPATHY IN RATS : A POSSIBLE INVOLVEMENT OF Α Research Article 2 ADRENOCEPTORS

  2012cites this paper
• The Mechanisms Underlying the Effects of C-Peptide on Type 1 Diabetic Neuropathy

  2012influential citation
• C-Peptide and Diabetic Neuropathy in Patients with Type 1 Diabetes

  2012cites this paper
• EFFECT OF AEGLE MARMELOS LEAF EXTRACT TREATMENT ON DIABETIC NEUROPATHY IN RATS: A POSSIBLE INVOLVEMENT OF A

  2012cites this paper
• [A new physiopathological classification of diabetic neuropathy].

  2012cites this paper
• Insulin Receptor Substrate 2 Expression and Involvement in Neuronal Insulin Resistance in Diabetic Neuropathy

  2011cites this paper
• Biological Significances, Diagnostic Values and Therapeutic Approach of Proinsulin Connecting Peptide

  2011cites this paper
• Pharmacological evaluation of rat dorsal root ganglion neurons as an in vitro model for diabetic neuropathy

  2011cites this paper
• Sex differences in the manifestation of peripheral diabetic neuropathy in gonadectomized rats: a correlation with the levels of neuroactive steroids in the sciatic nerve.

  2011cites this paper
• C‐peptide and long‐term complications of diabetes

  2011cites this paper
• C-peptide and diabetic encephalopathy.

  2011cites this paper
• Effects of Melatonin in Prevention of Neuropathy in STZ-Induced Diabetic Rats

  2011cites this paper
• Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle.

  2011cites this paper
• High glucose stimulates TNFα and MCP-1 expression in rat microglia via ROS and NF-κB pathways

  2011cites this paper
• Disorders of the Nervous System

  2011cites this paper
• Changes in serotoninergic and noradrenergic descending pain pathways during painful diabetic neuropathy: the preventive action of IGF1.

  2011cites this paper
• The effect of an exercise intervention on peripheral sensorimotor function in neuropathic diabetics

  2011cites this paper
• Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy.

  2010cites this paper
• Diabetes induces changes in ILK, PINCH and components of related pathways in the spinal cord of rats.

  2010cites this paper
• Angelica injection promotes peripheral nerve structure and function recovery with increased expressions of nerve growth factor and brain derived neurotrophic factor in diabetic rats.

  2010cites this paper
• Diabetic neuropathy: Electrophysiological and morphological study of peripheral nerve degeneration and regeneration in transgenic mice that express IFNβ in β cells

  2010cites this paper
• Diabetic neuropathy: still a challenge in pharmacology.

  2010cites this paper
• Taurine depletion and Schwann cell dysfunction in diabetic neuropathy

  2010cites this paper
• Glutamate Carboxypeptidase Inhibition Reduces the Severity of Chemotherapy-Induced Peripheral Neurotoxicity in Rat

  2010cites this paper
• The involvement of aldose reductase in alterations to neurotrophin receptors and neuronal cytoskeletal protein mRNA levels in the dorsal root ganglion of streptozotocin-induced diabetic rats.

  2010cites this paper
• Minocycline with aspirin: a therapeutic approach in the treatment of diabetic neuropathy

  2010cites this paper
• Global Transcriptional Programs in Peripheral Nerve Endoneurium and DRG Are Resistant to the Onset of Type 1 Diabetic Neuropathy in Ins2Akita/+ Mice

  2010cites this paper
• SREBPs: SREBP function in glia–neuron interactions

  2009cites this paper
• Carpal Tunnel Syndrome and Diabetes

  2009cites this paper
• The beneficial effects of C-Peptide on diabetic polyneuropathy.

  2009cites this paper
• Macrophage depletion delays progression of neuropathic pain in diabetic animals

  2009cites this paper